Jubilant Therapeutics Inc Information

Jubilant Therapeutics Inc is a patient focused bio-pharmaceutical company headquartered in the US, focused in targeted therapies in the areas of oncology and auto- immune disorders. The company leverages its expertise on Structure Based Drug Design (SBDD) to discover and develop small molecule therapeutics targeting first-in-class and challenging targets. The company is structured to synergistically complement with Jubilant Life Sciences value chain augmenting its discovery and development capabilities. Jubilant Therapeutics business strategy is to execute partnership or licensing with global pharmaceutical companies to bridge the gaps and progress the portfolio of research programs through to clinical development and commercialization. Key Therapeutic Areas • Oncology • Auto-immune Disorders Portfolio • Novel PAD4 inhibitors targeting auto-immune disorders • Dual LSD1/HDAC6 inhibitors targeting cancer • Novel small molecule PD-L1 inhibitors • Novel brain penetrating PRMT5 inhibitors targeting cancer